Fri Dec 3, 2021 – 10:44 am EST
Help JPII Medical Institute create a safe, ethical vaccine: LifeFunder.com
ANALYSIS
(LifeSiteNews) — A Swedish lab study released in mid-October found that the spike protein associated with the COVID-19 illness, and its experimental vaccines, enters the nucleus of cells and significantly interferes with DNA damage-repair functions compromising a person’s adaptive immunity and perhaps encouraging the formation of cancer cells.
The study, titled “SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro,” was released by the Department of Molecular Biosciences of Stockholm University, and began by discussing the enormous impact of the COVID-19 disease on the world today, and the necessity of healthy adaptive immunity for individuals to fight off the SARS–CoV–2 infection.
Yet, the researchers highlight how multiple clinical studies indicate “that patients with severe COVID–19 exhibit delayed and weak adaptive immune responses” for reasons that have remained unclear.
Offering a possible answer to this question, the authors “report that the SARS–CoV–2 spike protein significantly inhibits DNA damage repair, which is required for effective V(D)J recombination in adaptive immunity.”
“Mechanistically, we found that the spike protein localizes in the nucleus and inhibits DNA damage repair,”
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors